A multi-center, double-blind, randomized, parallel group study to evaluate the effects of two different doses of losartan on morbidity and mortality in Chinese patients with symptomatic heart failure intolerant of angiotensin converting enzyme inhibitor treatment
Background There have been no mortality/morbidity endpoint studies with Iosartan in Chinese heart failure patients. The objective was to evaluate the effects of high-dose vs. low-dose Iosartan on clinical outcomes in Chinese subjects with heart failure.
Gespeichert in:
| Veröffentlicht in: | Chinese medical journal 2012-11, Vol.125 (21), p.3868-3874 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 3874 |
|---|---|
| container_issue | 21 |
| container_start_page | 3868 |
| container_title | Chinese medical journal |
| container_volume | 125 |
| creator | Hu, Da-Yi Huang, Jun Cai, Nai-Sheng Zhu, Wen-Ling Li, Yi-Shi Massaad, Rachid Hanson, Mary E Dickstein, Kenneth |
| description | Background There have been no mortality/morbidity endpoint studies with Iosartan in Chinese heart failure patients. The objective was to evaluate the effects of high-dose vs. low-dose Iosartan on clinical outcomes in Chinese subjects with heart failure. |
| doi_str_mv | 10.3760/cma.j.issn.0366-6999.2012.21.023 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1124749959</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>43803135</cqvip_id><sourcerecordid>1124749959</sourcerecordid><originalsourceid>FETCH-LOGICAL-c237t-4fbbe249c731830dc226e83bcf36370d608c1cbae98405f64dd9611cf03e2d1b3</originalsourceid><addsrcrecordid>eNo9kU1v1DAQhgMCtUvhLyBz66EJ_kic5Fit-JIqcYHzyrEnG1f-2NqTVttfXy8tPdkzeuZ5x3JVXTLaiF7Sr9qr5raxOYeGCilrOY5jwynjDWcN5eJtteFdy-tOtuxdtXllzqsPOd9Syruul2fVOReMymGkmzdn18SvDm2tISCkK2LiOjmoJ2eDuSJJBRO9fYRyP6iknANH9imuB5JxNUeCkcC9cqtCILgAgXkGjZnEmeBDJMaWOhV18Wb413Yxq4QqkBiIj2myxuKRlJxThcqdKhvIdrEBMpRUtGU-kweLC8lHf8DoS0-TBYqHzMq6NUEZweig7IunEBX2NiKEXEw6hntIaMOeQHg8-hO72MliTAQTKPTF_7F6PyuX4dPLeVH9_f7tz_ZnffP7x6_t9U2tueixbudpAt6OuhdsENRoziUMYtKzkKKnRtJBMz0pGIeWdrNsjRklY3qmArhhk7ioLp-9hxTvVsi48zZrcE4FiGveMcbbvh3Hbizo5xd0nTyY3SFZr9Jx9__zCvDlGdBLDPu78sBXphUDFUx04gkf8bPi</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1124749959</pqid></control><display><type>article</type><title>A multi-center, double-blind, randomized, parallel group study to evaluate the effects of two different doses of losartan on morbidity and mortality in Chinese patients with symptomatic heart failure intolerant of angiotensin converting enzyme inhibitor treatment</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Hu, Da-Yi ; Huang, Jun ; Cai, Nai-Sheng ; Zhu, Wen-Ling ; Li, Yi-Shi ; Massaad, Rachid ; Hanson, Mary E ; Dickstein, Kenneth</creator><creatorcontrib>Hu, Da-Yi ; Huang, Jun ; Cai, Nai-Sheng ; Zhu, Wen-Ling ; Li, Yi-Shi ; Massaad, Rachid ; Hanson, Mary E ; Dickstein, Kenneth</creatorcontrib><description>Background There have been no mortality/morbidity endpoint studies with Iosartan in Chinese heart failure patients. The objective was to evaluate the effects of high-dose vs. low-dose Iosartan on clinical outcomes in Chinese subjects with heart failure.</description><identifier>ISSN: 0366-6999</identifier><identifier>EISSN: 2542-5641</identifier><identifier>DOI: 10.3760/cma.j.issn.0366-6999.2012.21.023</identifier><identifier>PMID: 23106890</identifier><language>eng</language><publisher>China</publisher><subject>Angiotensin II Type 1 Receptor Blockers - therapeutic use ; Angiotensin-Converting Enzyme Inhibitors - therapeutic use ; Double-Blind Method ; Female ; Heart Failure - drug therapy ; Humans ; Losartan - adverse effects ; Losartan - therapeutic use ; Male ; Middle Aged ; 中国 ; 低剂量 ; 发病率 ; 心脏 ; 死亡率 ; 血管紧张素转换酶抑制剂 ; 衰竭 ; 评估</subject><ispartof>Chinese medical journal, 2012-11, Vol.125 (21), p.3868-3874</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/85656X/85656X.jpg</thumbnail><link.rule.ids>314,776,780,860,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23106890$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hu, Da-Yi</creatorcontrib><creatorcontrib>Huang, Jun</creatorcontrib><creatorcontrib>Cai, Nai-Sheng</creatorcontrib><creatorcontrib>Zhu, Wen-Ling</creatorcontrib><creatorcontrib>Li, Yi-Shi</creatorcontrib><creatorcontrib>Massaad, Rachid</creatorcontrib><creatorcontrib>Hanson, Mary E</creatorcontrib><creatorcontrib>Dickstein, Kenneth</creatorcontrib><title>A multi-center, double-blind, randomized, parallel group study to evaluate the effects of two different doses of losartan on morbidity and mortality in Chinese patients with symptomatic heart failure intolerant of angiotensin converting enzyme inhibitor treatment</title><title>Chinese medical journal</title><addtitle>Chinese Medical Journal</addtitle><description>Background There have been no mortality/morbidity endpoint studies with Iosartan in Chinese heart failure patients. The objective was to evaluate the effects of high-dose vs. low-dose Iosartan on clinical outcomes in Chinese subjects with heart failure.</description><subject>Angiotensin II Type 1 Receptor Blockers - therapeutic use</subject><subject>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</subject><subject>Double-Blind Method</subject><subject>Female</subject><subject>Heart Failure - drug therapy</subject><subject>Humans</subject><subject>Losartan - adverse effects</subject><subject>Losartan - therapeutic use</subject><subject>Male</subject><subject>Middle Aged</subject><subject>中国</subject><subject>低剂量</subject><subject>发病率</subject><subject>心脏</subject><subject>死亡率</subject><subject>血管紧张素转换酶抑制剂</subject><subject>衰竭</subject><subject>评估</subject><issn>0366-6999</issn><issn>2542-5641</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kU1v1DAQhgMCtUvhLyBz66EJ_kic5Fit-JIqcYHzyrEnG1f-2NqTVttfXy8tPdkzeuZ5x3JVXTLaiF7Sr9qr5raxOYeGCilrOY5jwynjDWcN5eJtteFdy-tOtuxdtXllzqsPOd9Syruul2fVOReMymGkmzdn18SvDm2tISCkK2LiOjmoJ2eDuSJJBRO9fYRyP6iknANH9imuB5JxNUeCkcC9cqtCILgAgXkGjZnEmeBDJMaWOhV18Wb413Yxq4QqkBiIj2myxuKRlJxThcqdKhvIdrEBMpRUtGU-kweLC8lHf8DoS0-TBYqHzMq6NUEZweig7IunEBX2NiKEXEw6hntIaMOeQHg8-hO72MliTAQTKPTF_7F6PyuX4dPLeVH9_f7tz_ZnffP7x6_t9U2tueixbudpAt6OuhdsENRoziUMYtKzkKKnRtJBMz0pGIeWdrNsjRklY3qmArhhk7ioLp-9hxTvVsi48zZrcE4FiGveMcbbvh3Hbizo5xd0nTyY3SFZr9Jx9__zCvDlGdBLDPu78sBXphUDFUx04gkf8bPi</recordid><startdate>20121105</startdate><enddate>20121105</enddate><creator>Hu, Da-Yi</creator><creator>Huang, Jun</creator><creator>Cai, Nai-Sheng</creator><creator>Zhu, Wen-Ling</creator><creator>Li, Yi-Shi</creator><creator>Massaad, Rachid</creator><creator>Hanson, Mary E</creator><creator>Dickstein, Kenneth</creator><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20121105</creationdate><title>A multi-center, double-blind, randomized, parallel group study to evaluate the effects of two different doses of losartan on morbidity and mortality in Chinese patients with symptomatic heart failure intolerant of angiotensin converting enzyme inhibitor treatment</title><author>Hu, Da-Yi ; Huang, Jun ; Cai, Nai-Sheng ; Zhu, Wen-Ling ; Li, Yi-Shi ; Massaad, Rachid ; Hanson, Mary E ; Dickstein, Kenneth</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c237t-4fbbe249c731830dc226e83bcf36370d608c1cbae98405f64dd9611cf03e2d1b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Angiotensin II Type 1 Receptor Blockers - therapeutic use</topic><topic>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</topic><topic>Double-Blind Method</topic><topic>Female</topic><topic>Heart Failure - drug therapy</topic><topic>Humans</topic><topic>Losartan - adverse effects</topic><topic>Losartan - therapeutic use</topic><topic>Male</topic><topic>Middle Aged</topic><topic>中国</topic><topic>低剂量</topic><topic>发病率</topic><topic>心脏</topic><topic>死亡率</topic><topic>血管紧张素转换酶抑制剂</topic><topic>衰竭</topic><topic>评估</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hu, Da-Yi</creatorcontrib><creatorcontrib>Huang, Jun</creatorcontrib><creatorcontrib>Cai, Nai-Sheng</creatorcontrib><creatorcontrib>Zhu, Wen-Ling</creatorcontrib><creatorcontrib>Li, Yi-Shi</creatorcontrib><creatorcontrib>Massaad, Rachid</creatorcontrib><creatorcontrib>Hanson, Mary E</creatorcontrib><creatorcontrib>Dickstein, Kenneth</creatorcontrib><collection>中文科技期刊数据库</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Chinese medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hu, Da-Yi</au><au>Huang, Jun</au><au>Cai, Nai-Sheng</au><au>Zhu, Wen-Ling</au><au>Li, Yi-Shi</au><au>Massaad, Rachid</au><au>Hanson, Mary E</au><au>Dickstein, Kenneth</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A multi-center, double-blind, randomized, parallel group study to evaluate the effects of two different doses of losartan on morbidity and mortality in Chinese patients with symptomatic heart failure intolerant of angiotensin converting enzyme inhibitor treatment</atitle><jtitle>Chinese medical journal</jtitle><addtitle>Chinese Medical Journal</addtitle><date>2012-11-05</date><risdate>2012</risdate><volume>125</volume><issue>21</issue><spage>3868</spage><epage>3874</epage><pages>3868-3874</pages><issn>0366-6999</issn><eissn>2542-5641</eissn><abstract>Background There have been no mortality/morbidity endpoint studies with Iosartan in Chinese heart failure patients. The objective was to evaluate the effects of high-dose vs. low-dose Iosartan on clinical outcomes in Chinese subjects with heart failure.</abstract><cop>China</cop><pmid>23106890</pmid><doi>10.3760/cma.j.issn.0366-6999.2012.21.023</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0366-6999 |
| ispartof | Chinese medical journal, 2012-11, Vol.125 (21), p.3868-3874 |
| issn | 0366-6999 2542-5641 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1124749959 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Angiotensin II Type 1 Receptor Blockers - therapeutic use Angiotensin-Converting Enzyme Inhibitors - therapeutic use Double-Blind Method Female Heart Failure - drug therapy Humans Losartan - adverse effects Losartan - therapeutic use Male Middle Aged 中国 低剂量 发病率 心脏 死亡率 血管紧张素转换酶抑制剂 衰竭 评估 |
| title | A multi-center, double-blind, randomized, parallel group study to evaluate the effects of two different doses of losartan on morbidity and mortality in Chinese patients with symptomatic heart failure intolerant of angiotensin converting enzyme inhibitor treatment |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T02%3A01%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20multi-center,%20double-blind,%20randomized,%20parallel%20group%20study%20to%20evaluate%20the%20effects%20of%20two%20different%20doses%20of%20losartan%20on%20morbidity%20and%20mortality%20in%20Chinese%20patients%20with%20symptomatic%20heart%20failure%20intolerant%20of%20angiotensin%20converting%20enzyme%20inhibitor%20treatment&rft.jtitle=Chinese%20medical%20journal&rft.au=Hu,%20Da-Yi&rft.date=2012-11-05&rft.volume=125&rft.issue=21&rft.spage=3868&rft.epage=3874&rft.pages=3868-3874&rft.issn=0366-6999&rft.eissn=2542-5641&rft_id=info:doi/10.3760/cma.j.issn.0366-6999.2012.21.023&rft_dat=%3Cproquest_pubme%3E1124749959%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1124749959&rft_id=info:pmid/23106890&rft_cqvip_id=43803135&rfr_iscdi=true |